INOVIQ Ltd (ASX:IIQ)'s CEO Leearne Hinch speaks with Proactive’s Elisha Newell about the company’s expansion in the US. IIQ has now appointed a contract sales team to help roll out products in the US, most notably its EXO-NET® research tool. The company intends to promote and potentially sell the product to academia, research groups and biopharma companies researching diseases based on exosome biomarkers.
INOVIQ expands US footprint with new sales team
